PPARA and steatosis: Mechanistically, miR-483-5p targets Peroxisome-proliferator-activated receptor alpha (PPARα) and Tissue inhibitor of metalloproteinases 2 (TIMP2) gene expression leading to the suppression of steatosis and fibrosis.